|
Neratinib Shows Promise in Treatment of HER2-positive Breast Cancer
1 day ago
According to the results of a Phase II clinical trial, the addition of the investigational drug neratinib to paclitaxel chemotherapy produced promising response rates among women with metastatic, HER2-positive breast cancer. These results were presented at the 2009 San Antonio Breast Cancer Symposiu ...
Kansas City Cancer Center - kccancercenter.com
|
|
The Plot Sickens
1 day ago
by Leanne
Apologies about that mysterious reference to “developments in development” – I was waiting to speak to my doctor, and now that I know what is going on and have shared it with family, I can finally blog about it. Basically, the nodules in my lungs have turned out to be metastasized breast cancer. Thi ...
Chatelaine - blog.en.chatelaine.com · Rank: 25,382 · 14 references
|
|
Neratinib Shows Promise in Treatment of HER2-positive Breast Cancer
1 day ago
by mjames
According to the results of a Phase II clinical trial, the addition of the investigational drug neratinib to paclitaxel chemotherapy produced promising response rates among women with metastatic, HER2-positive breast cancer. These results were presented at the 2009 San Antonio Breast Cancer Symposiu ...
CancerConsultants - cancerconsultants.com · Rank: 133,463 · 19 references
|
|
A Free Cruise? Where do I sign up?
1 day ago
by livingbeyondbc
We at LBBC are committed to finding cool, unique opportunities for breast cancer survivors and caregivers to share their stories and get support. We’ve found something amazing and can’t wait to share it with all of you… A free cruise! Amoena USA Corporation and Young Survival Coalition are celebrati ...
Livingbeyondbc's Blog - livingbeyondbc.wordpress.com · Rank: 161,111 · 2 references
|
|
Neratinib Shows Promise in Treatment of HER2-positive Breast Cancer
1 day ago
According to the results of a Phase II clinical trial, the addition of the investigational drug neratinib to paclitaxel chemotherapy produced promising response rates among women with metastatic, HER2-positive breast cancer. These results were presented at the 2009 San Antonio Breast Cancer Symposiu ...
Greater Dayton Cancer Center - greaterdaytoncancercenter.com
|
|
Neratinib Shows Promise in Treatment of HER2-positive Breast Cancer
1 day ago
According to the results of a Phase II clinical trial, the addition of the investigational drug neratinib to paclitaxel chemotherapy produced promising response rates among women with metastatic, HER2-positive breast cancer. These results were presented at the 2009 San Antonio Breast Cancer Symposiu ...
Ironwood Cancer Research ... - ironwoodcrc.com
|
|
Neratinib Shows Promise in Treatment of HER2-positive Breast Cancer
1 day ago
According to the results of a Phase II clinical trial, the addition of the investigational drug neratinib to paclitaxel chemotherapy produced promising response rates among women with metastatic, HER2-positive breast cancer. These results were presented at the 2009 San Antonio Breast Cancer Symposiu ...
Charlotte Cancer - charlottecancer.com
|
|